Ionis Pharmaceuticals, Inc.

IONS · NASDAQ
Analyze with AI
10/28/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$129$124-$147-$104
Dep. & Amort.$12$5$4,815$5
Deferred Tax$0$0$0$0
Stock-Based Comp.$31$30$30$36
Change in WC$70-$28-$41-$61
Other Non-Cash-$115$21-$4,807$8
Operating Cash Flow-$131$151-$151-$116
Investing Activities
PP&E Inv.-$5-$12-$13-$25
Net Acquisitions$0$0$0$0
Inv. Purchases-$324-$492-$311-$334
Inv. Sales/Matur.$422$386$495$430
Other Inv. Act.-$2-$2-$1-$3
Investing Cash Flow$91-$120$170$68
Financing Activities
Debt Repay.-$0-$0-$0-$45
Stock Issued$81$1$2$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$81$1$2-$44
Forex Effect-$0$1$0-$0
Net Chg. in Cash$41$33$22-$93
Supplemental Information
Beg. Cash$297$264$242$335
End Cash$338$297$264$242
Free Cash Flow-$135$137-$163-$142
Ionis Pharmaceuticals, Inc. (IONS) Financial Statements & Key Stats | AlphaPilot